| ONLINE IL SITO GIMBE SULL'EMERGENZA COVID-19 |
News Metodologiche
Reporting of conflicts of interest from drug trials in Cochrane reviews: cross sectional study
BMJ 2012;345:e5155
Sample size calculations: should the emperor-clothes be off the peg or made to measure?
BMJ 2012;345:e5278
JAMA 2012;308:979-980
PLoS Med 9(9): e1001308
What Business Are We In? The Emergence of Health as the Business of Health Care
N Engl J Med 2012; 367:888-889
From Sick Care to Health Care - Reengineering Prevention into the U.S. System
N Engl J Med 2012; 367:889-891
A Systemic Approach to Containing Health Care Spending
N Engl J Med 2012; 367:949-954
Bending the Cost Curve through Market-Based Incentives
N Engl J Med 2012; 367:954-958
Ethical Considerations in Studying Drug Safety — The Institute of Medicine Report
N Engl J Med 2012; 367:959-964
Clinical Trial Data as a Public Good
JAMA 2012;308:871-872
Pagina aggiornata il 13/06/2026



